Hence, upregulation of CDKN2A, MEX3A, RPL39L, VARS, GSPT1, SNRPE, SSR1, and TIA1 is associated with poor survival in breast and colon cancer patients. The gene discussed is VARS1; the disease is malignant colon neoplasm.